The FDA has issued formal safety alerts about semaglutide dosing errors from compounded products
When transitioning from semaglutide to another diabetes medication, clinicians should anticipate overlapping drug effects for several weeks
Genetic studies of body mass index yield new insights for obesity biology
Avoid consuming sugary foods, refined carbohydrates, sodas, and energy drinks
If side effects are persistent or severe, the healthcare provider may adjust the dose or explore strategies to alleviate discomfort, including considering a modified dosing schedule in select cases
This section will discuss the expected benefits, potential risks, and the importance of ongoing monitoring and follow-up with healthcare providers